Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Mississippi for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Mississippi only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Mississippi (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Avit Gremillion (NPI 1861479529)

Field	Value
Entity Type	Individual
Organization	Avit Gremillion
Address	962 Tommy Munro Dr Ste E
City	Biloxi
State	MS
ZIP	39532
Taxonomy	Ophthalmology Physician
NPI Enumerated	December 23, 2005

Payer Source	Total Paid
Medicare	$1.8M
Medicaid	$0

Key Findings

This provider reports $1.8M in total Medicare revenue and has no Medicaid billing on file (none below), making their publicly visible business effectively single‑payer Medicare in scale. The NPI was enumerated on 2005-12-23 (~21 years ago), indicating long tenure and an established billing history with Medicare.

Revenue is highly concentrated in intravitreal drug administration and related drug billing: the precomputed top three Medicare codes (J0178, J2777, J3490) account for 61.1% of the provider's total Medicare revenue. J0178 ($579.7K, 32.6%) and J2777 ($356.7K, 20.0%) are the largest single contributors, with J3490 contributing $152K (8.5%).

The procedural and service mix points to a retina‑focused ophthalmology operation centered on frequent intravitreal injections and advanced retinal imaging. High‑revenue injectables (J0178, J2777, J2781) are paired with extensive diagnostic imaging and angiography (92134, 92242, 92273), supporting a practice model that delivers drug therapies alongside in‑office diagnostic services.

Despite injections driving revenue, the provider is not a dominant national player on those drug codes: J0178 ranks #1452 of 3204 providers (55th percentile; typical, unremarkable volume), J2777 ranks #859 of 2039 (58th percentile; typical, unremarkable volume), and J3490 ranks #933 of 2838 (67th percentile; typical, unremarkable volume). These standings indicate moderate, peer‑typical participation in high‑cost drug administration rather than outsized national market share.

Several non‑drug services are extreme outliers in volume relative to national peers, which signals a heavy emphasis on retinal diagnostics and frequent follow‑up visits. 92134 is an extreme outlier at the 99th percentile (3K claims, $78.5K revenue), and evaluation/management codes 99213 (1.1K claims, $67.7K revenue) and 99214 (900 claims, $72K revenue) sit at the 99th and 97th percentiles respectively, described as extreme outlier and notably above typical national volume. This pattern suggests an unusually high throughput of imaging and office visits supporting the injection practice.

Angiography and electrophysiology volumes are also elevated relative to peers, indicating a full retinal diagnostic suite on site: 92242 (345 claims, $58K revenue) is reported at the 90th percentile (typical, unremarkable volume), 92273 (376 claims, $32.3K revenue) is at the 94th percentile (typical, unremarkable volume), and 92235 (239 claims, $21.3K revenue) sits at the 89th percentile (typical, unremarkable volume). These patterns reinforce the operational profile of a retina specialty that performs advanced imaging and functional testing rather than a general ophthalmology clinic.

There is evidence of adoption of multiple intravitreal agents and biosimilars: Q5128 (ranibizumab biosimilar) generates $117.8K (6.6% of Medicare revenue) and J2781 (pegcetacoplan) contributes $88.3K (5.0%). At the same time, J2777 shows unusually high claim counts (12.3K claims, $356.7K revenue) but remains in the mid‑peer percentile (58th; typical, unremarkable volume), suggesting operational scale in administering newer agents without outlier national ranking for those specific drug codes.

For payers and network managers evaluating contracting risk, the profile shows concentrated Medicare dependence ($1.8M vs. none for Medicaid) and operational exposure to policy or price changes affecting intravitreal drugs and high‑volume retinal imaging. The combination of long tenure (enumerated 2005-12-23 (~21 years ago)), concentrated drug revenue (top 3 = 61.1%), and extreme imaging/visit volumes signals a specialized retina practice with predictable Medicare revenue but limited Medicaid footprint.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

24 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	850	$680	$579.7K
J2777	Injection, faricimab‑svoa, 0.1 mg	12,300	$30	$356.7K
J3490	Unclassified drugs	90	$1,770	$152K
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	550	$220	$117.8K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,340	$80	$103.4K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	740	$120	$88.3K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	3,020	$30	$78.5K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	900	$80	$72K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	1,150	$60	$67.7K
92242	The provider injects two different special dyes into one or both eyes that cause the blood vessels to stand out in photographic images timed so that multiple frames are taken in rapid succession. He…	350	$170	$58K

Showing 1–10 of 24

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 24 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Mississippi Distribution

Avit Gremillion — 4 of 24 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Mississippi

Full comparison — all codes billed, vs. state median

24 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	10	20	670	$680	$990.1K
J2777	3	10	8,460	$30	$325.2K
J2781	3	10	950	$120	$141.8K
67028	9	30	600	$80	$107K
Q5128	2	10	440	$220	$87.3K
J7999	5	10	150	$150	$64.6K
92242	1	10	180	$170	$30.5K
92014	334	350	170	$70	$23K
99214	295	4,110	170	$70	$21.9K
J9035	13	10	210	$50	$18.1K

Showing 1–10 of 24

Related Providers

Other providers that share a Tax Identification Number (TIN) with Avit Gremillion, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Ryan Olson	FL	Anatomic Pathology & Clinical Pathology Physician	$12.8M	$80
Shanda Jackson	LA	Family Nurse Practitioner	$4M	$0
James Russo	LA	Radiation Oncology Physician	$3.5M	$0
Stephen Price	LA	Physician Assistant	$3.4M	$0
Jyothi Mallepalli	LA	Rheumatology Physician	$3.2M	$0
Kirtan Koticha	LA	Hematology & Oncology Physician	$3.1M	$0
Russell Fileccia	LA	Cardiovascular Disease Physician	$2.6M	$0
Ruben Grigorian	LA	Ophthalmology Physician	$2.4M	$57.1K
Jeffrey Gosslee	LA	Retina Specialist (Ophthalmology) Physician	$2.3M	$4.5K
Jonathan Perkins	LA	Retina Specialist (Ophthalmology) Physician	$1.7M	$160.4K

Nearby Providers

Other providers in the same ZIP code as Avit Gremillion, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Nursing Management, Inc.	MS	Nursing Care Agency	$0	$42.3M
Gulf Coast Abc Pediatrics, Inc.	MS	Pediatrics Physician	$0	$2.1M
Lighthouse Pediatrics	MS	Pediatrics Physician	$0	$1.6M
Golden Oak Senior Services LLC Dba Lemoyne Place	MS	Assisted Living Facility	$0	$1.5M
Antoine Rizk	MS	Cardiovascular Disease Physician	$509.1K	$0
Cedar Lake Open Mri LLC	MS	Diagnostic Radiology Physician	$276.3K	$181.6K
Paul Mullen	MS	Cardiovascular Disease Physician	$394.4K	$0
Michael Cunningham	MS	Interventional Cardiology Physician	$348.9K	$0
Rainna Bahadur	MS	Ophthalmology Physician	$288.7K	$0
Eva Magiros	MS	Cardiovascular Disease Physician	$287.2K	$0

Avit Gremillion — Billing Profile & Reimbursement Data

Sign up for Avit Gremillion — Billing Profile & Reimbursement Data policy alerts

Avit Gremillion — Billing Profile & Reimbursement Data

Sign up for Avit Gremillion — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References